Dr. Lewis Cantley, a leading cancer researcher, credited with discovering a family of enzymes fundamental to understanding cancer, has been named director of the newly established cancer center at Weill Cornell Medical College and NewYork-Presbyterian Hospital.

NewYork-Presbyterian Hospital/Weill Cornell Medical Center is the first and only hospital in the five boroughs of New York City to offer women with early stage breast cancer INTRABEAM radiotherapy, an innovative radiation treatment delivered in a single dose at the time of surgery.

Dr. Matthew E. Fink, a leader in stroke and critical care neurology, has been named chairman of the Department of Neurology at Weill Cornell Medical College and neurologist-in-chief at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.

NewYork-Presbyterian Hospital has been honored with a 2012 Environmental Excellence award for its commitment to environmentally responsible operations in areas such as waste reduction, source reduction programs and mercury elimination.

NewYork-Presbyterian Hospital announced today that it has appointed real estate developer Bruce A. Beal, Jr., private equity executive Russell Lloyd Carson and former U.S. Secretary of Labor Elaine L. Chao to its Board of Trustees. The Board oversees the five-campus, 2,409-bed hospital, which is one of the leading health care institutions in the country.

September is National Childhood Obesity Awareness Month. For Nutrition and Weight Management please visit NewYork-Presbyterian Komansky Center for Children's Health and NewYork-Presbyterian Morgan Stanley Children's Hospital's websites.

NewYork-Presbyterian/Weill Cornell Medical Center is one of six institutions selected to join the newly-founded MDS Clinical Research Consortium. The Consortium's mission is to significantly advance treatments and patient outcomes for Myelodysplastic Syndromes (MDS) through innovative research and clinical trials.

The number two cancer killer in the U.S. is often preventable and highly curable.